Vimian is a global animal health company with a passion for making a positive impact through offering animals the best available care. The Group puts science, technology and its customers’ needs at the centre, aiming to deliver effective solutions to animals and veterinary professionals around the world.

During the period between 2015-2018, Fidelio acquired Nextmune, Indical, VetFamily and Movora - four prominent companies within the animal health market, each specialising in their respective niche markets, namely Speciality Pharma, Diagnostics, Veterinary Services and MedTech. In 2021, recognising an attractive opportunity to accelerate continued organic growth as well as to improve collaborative efforts, Fidelio made the strategic decision to gather all four businesses under a shared umbrella, with the foundation of Vimian – a global group of leading niche animal health companies.

In June 2021, Vimian was listed on the Stockholm Stock Exchange, with Fidelio maintaining its role as an active and supportive majority owner.